|
|
Thomson Financial Business Description:
| The Group's principal activity is developing and commercialising companion diagnostics and targeted medicines to treat patients more effectively. TThe Group focuses on diseases of the Central Nervous System resulting in the identification of a blood diagnostic test, PsychINDx, which classifies patients with schizophrenia/bipolar disorder into four subgroups. PsychINDx has the potential to improve the treatment of patients with schizophrenia/bipolar disorder. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Curidium Medica PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
